Table: Modalis Therapeutics - 9-MTH group results

Modalis Therapeutics

07/11/2023 06:00

Nov 7 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales                                40 mln                     
                (-100.0 pct)                                      
  Operating       loss 1.61           loss 1.44                   
  Recurring       loss 1.54           loss 1.31                   
  Net             loss 1.58           loss 1.31                   
  EPS          loss 52.29 yen      loss 45.04 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T